Tag: Payers

Covid-19 disrupted payer operations

October 8, 2021

Covid-19 changed the landscape of healthcare. Pharma companies had to ramp up their digital outreach to continue uninterrupted business.

How are patients’ perceptions about drug copays, pharmaceutical industry, and digitalization of healthcare evolving during COVID-19 pandemic?

May 18, 2021

How are payers’ attitudes about home infusion evolving in the COVID environment?

March 2, 2021

Payers have covered home infusion services as part of the medical benefit for years. With the effects of COVID-19 restricting access to hospitals and physician offices for elective procedures, the availability of home infusion services has increased in importance.

Copay Accumulators: Shifting cost of care from plan sponsors to patients?

January 27, 2021

Health insurers argue that copay accumulator programs (CAPs) incentivize patients to shift to less expensive generic alternatives.

How do payers perceive copay assistance programs?

January 12, 2021

How has COVID-19 pandemic disrupted B2B relationships between industry and insurers?

July 7, 2020

How has COVID-19 affected payers regarding orphan drugs? Opportunity or threat?

June 16, 2020

COVID-19 disruption to oncology practices and patients

June 2, 2020